Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EURO-LB 02: Treatment Protocol for T-Cell and B-Precursor Cell Lymphoblastic Lymphoma
2007-005396-34Phase 3Completed
- Sponsor
- University of Birmingham
- Start
- Aug 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in lymphoblastic lymphoma (LL), T-lymphoblastic lymphoma (T-LBL), sponsored by University of Birmingham. Started Aug 2010; status: completed.
02
Drugs
dexamethasone
03
Conditions
lymphoblastic lymphoma (LL)T-lymphoblastic lymphoma (T-LBL)
Beyond the preview
Go deeper on 2007-005396-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005396-34.